Remove Clinical Practice Remove Education Remove Insurance Remove Screening
article thumbnail

Hearing Loss in Geriatrics and Palliative Care: A Podcast with Nick Reed and Meg Wallhagen

GeriPal

Was there any mention about the impact that hearing loss has in communication or what we should do about it in clinical practice? Screening for addressing hearing loss should be an integral part of what we do in geriatrics and palliative care, but it often is either a passing thought or completely ignored. I’m guessing not.

IT 102
article thumbnail

Social Risk Burden and Its Impact on Healthcare Use in IBD

Physician's Weekly

High social risk burden in adults with IBD drives emergency care use and medication gaps—spotlighting the urgent need for social screening in clinical practice. Social risk burden was categorized as none (0/6 domains), mild (1/6), moderate (2/6), and severe (≥3/6). 10.2]) and cost-related medication non-adherence (OR, 11.8 [2.7-52.1]),

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Substance Use Disorder in Aging and Serious Illness: A Podcast with Katie Fitzgerald Jones, Jessica Merlin, Devon Check

GeriPal

After discussing screening options for substance use disorder, we go on to talk about both the treatments for it and the issues that arise. So, we are not screening for substance use in cancer care, so we don’t get good estimates among people with cancer, which is really how we would prefer to ask the question.

Illness 136
article thumbnail

CDC Emphasizes Opioid Guideline is Voluntary and Should Support, Not Supplant, Patient Care

FDA Law Blog

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. Patient education and discussion are critical before initiating therapy. Only clinicians familiar with dosing and absorption of ER/LA opioid transdermal fentanyl who educate their patients about it should consider prescribing it.

article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. Stacy: We’re using anxiety, baseline anxiety, as our screening. Alex: So that’s not our prototypical screening ESAS question. Do they have to have distress, pain, depression?